investigational new drug (IND), a drug not yet approved for marketing by the U.S. Food and Drug Administration (FDA) and available only for use in experiments to determine its safety and effectiveness. The use of an investigational new drug in human subjects requires approval by the FDA of an application that includes reports of animal toxicity tests, descriptions of proposed clinical trials, and a list of the investigators and their qualifications.
